Добірка наукової літератури з теми "Diabetes Iran"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Diabetes Iran".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Diabetes Iran"
Sanjari, Mahnaz, Maryam Aalaa, Mohammad Reza Amini, Neda Mehrdad, Hosein Adibi, Ensieh Nasli Esfahani, and Bagher Larijani. "Conceptual map of diabetes education: necessity of establishing iran diabetes academy." Journal of Diabetes & Metabolic Disorders 18, no. 2 (October 8, 2019): 729–31. http://dx.doi.org/10.1007/s40200-019-00441-y.
Повний текст джерелаMohammad Alavinia, Seyed, Koorosh Etemad, Alireza Mahdavi, Maryam Omidvar, Sara Imanpour, Rudmilla Rahman, Muhiuddin Haider, and Jared Frank. "Gestational diabetes mellitus in Iran – experience from the National Diabetes Program." International Journal of Pharmaceutical and Healthcare Marketing 6, no. 2 (June 22, 2012): 156–66. http://dx.doi.org/10.1108/17506121211243077.
Повний текст джерелаOzma, Mahdi Asghari, Jalil Rashedi, Behroz Mahdavi Poor, Ali Vegari, Vahid Asgharzadeh, Hossein Samadi Kafil, Abdolhassan Kazemi, Leyla Sahebi, and Mohammad Asgharzadeh. "Tuberculosis and Diabetes Mellitus in Northwest of Iran." Infectious Disorders - Drug Targets 20, no. 5 (December 9, 2020): 667–71. http://dx.doi.org/10.2174/1871526519666190715142100.
Повний текст джерелаPishdad, G. R. "Low Incidence of Type 1 Diabetes in Iran." Diabetes Care 28, no. 4 (March 25, 2005): 927–28. http://dx.doi.org/10.2337/diacare.28.4.927.
Повний текст джерелаBeiranvand, Fatemeh, and Mohsen Alizadeh. "Plants for remedies of diabetes mellitus in Iran." Plant Biotechnology Persa 1, no. 1 (November 1, 2019): 36–38. http://dx.doi.org/10.29252/pbp.1.1.36.
Повний текст джерелаJafarvand, Elnaz, Amin Ataey, and Sare Edalati. "Epidemiology and Death Trends Due to Diabetes in Iran." Quarterly of the Horizon of Medical Sciences 27, no. 2 (April 1, 2021): 198–213. http://dx.doi.org/10.32598/hms.27.2.2764.1.
Повний текст джерелаPishdad, G. R. "Age at Diagnosis of Non-Insulin-Dependent Diabetes Mellitus in Southern Iran." Journal of International Medical Research 23, no. 5 (September 1995): 381–85. http://dx.doi.org/10.1177/030006059502300509.
Повний текст джерелаSarayani, Amir, Arash Rashidian, and Kheirollah Gholami. "Low utilisation of diabetes medicines in Iran, despite their affordability (2000–2012): a time-series and benchmarking study." BMJ Open 4, no. 10 (October 2014): e005859. http://dx.doi.org/10.1136/bmjopen-2014-005859.
Повний текст джерелаMorovatdar, Negar, Gholamreza Tayebi Nasrabad, Konstantinos Tsarouhas, and Ramin Rezaee. "Etiology of Renal Replacement Therapy in Iran." International Journal of Nephrology 2019 (November 26, 2019): 1–5. http://dx.doi.org/10.1155/2019/5010293.
Повний текст джерелаAzizi, F., M. M. Gouya, P. Vazirian, P. Dolatshahi, and S. Habibian. "The diabetes prevention and control programme of the Islamic Republic of Iran." Eastern Mediterranean Health Journal 9, no. 5-6 (March 31, 2003): 1114–21. http://dx.doi.org/10.26719/2003.9.5-6.1114.
Повний текст джерелаДисертації з теми "Diabetes Iran"
White, Desley Louise. "Non-transferrin-bound iron and protein glycation in type 2 diabetes." Thesis, University of Plymouth, 2012. http://hdl.handle.net/10026.1/1181.
Повний текст джерелаAljwaid, Husam O. Dakhil. "Relationships between iron, oxidative stress, glycated proteins and the development of atherosclerosis in Type 2 diabetes." Thesis, University of Plymouth, 2015. http://hdl.handle.net/10026.1/3222.
Повний текст джерелаFernández, Cao José Cándido. "Iron excess and risk of type 2 diabetes mellitus in a prospective cohort of mediterranean population." Doctoral thesis, Universitat Rovira i Virgili, 2016. http://hdl.handle.net/10803/378354.
Повний текст джерелаAntecedentes:El consumo de hierro hemo y los depósitos de hierro se han asociado con el riesgo de diabetes mellitus tipo 2 (DMT2) en cohortes estadounidenses, chinas, y del norte de Europa, sin embargo estas relaciones no han sido estudiadas en poblaciones del sur de Europa. Objetivos:Evaluar, prospectivamente, el efecto de la ingesta elevada de hierro y el estado elevado de hierro en la aparición de la DMT2 en población mediterránea adulta, y estudiar la relación entre el estado del hierro y la osteocalcina. Métodos:Los participantes fueron hombres y mujeres de 55 a 80 años del estudio PREDIMED. La DMT2 fue diagnosticada utilizando los criterios de la ADA. Se recogieron datos sociodemográficos, antropométricos, de estilo de vida, estado de hierro, perfil lipídico, metabolismo de la glucosa e inflamación. En un estudio observacional en 1.073 personas, 131 diabéticos incidentes, se evaluó la asociación entre la ingesta de hierro y la DMT2. Se analizó transversalmente en 423 sujetos la relación entre el estado de hierro y la osteocalcina. Finalmente, un estudio casos-control anidado fue diseñado para evaluar la asociación entre el estado de hierro, medido mediante la ferritina sérica (FS) y el receptor soluble de transferrina (sTfR),y el riesgo de DMT2 en 459 participantes, 153 diabéticos incidentes. Resultados:Se encontró que una ingesta elevada de hierro hemo aumenta el riesgo de DMT2 en un 30%. Además, los valores de FS>257μg/L en varones y >139μg/L en mujeres se asociaron con DMT2. También se encontró asociación entre el ratio sTfR:ferritina y la DMT2, pero no con el sTfR. Tanto SF como el sTfR se relacionan con la osteocalcina. Conclusiones:En una población mediterránea adulta de alto riesgo cardiovascular, una ingesta elevada de hierro hemo y unos depósitos elevados de hierro aumentan el riesgo de DMT2. La relación entre el estado de hierro y la osteocalcina es controvertida.
Background: The intake of haem iron intake as well as body iron stores have been associated with the risk of developing type 2 diabetes mellitus (T2DM) in U.S., Chinese, and northern European cohorts, however these relationships have not been studied in southern European populations. Objectives: To assess, prospectively, the effect of elevated dietary iron intake and body iron status on the onset of T2DM in an adult Mediterranean population, and to evaluate the relationship between iron status and osteocalcin as a potential mechanism for explaining iron-induced T2DM. Methods: Participants were men and women aged 55 to 80 years from the PREDIMED study. New-onset T2DM during follow-up was diagnosed using the criteria of the American Diabetes Association. Socio-demographic, anthropometric, lifestyle, dietary intake, iron status, lipid profile, glucose metabolism, inflammation variables were collected at baseline. An observational cohort study was conducted in 1,073 individuals, 131 incident diabetics, to assess the association between iron intake and T2DM. A cross-sectional study was carried out in 423 subjects to evaluate the relationship between iron status and osteocalcin. Finally, a prospective nested case-control study was design to assess the association between body iron status, measured as serum ferritin (SF) and soluble transferrin receptor (sTfR) and its ratio, with T2DM in 459 participants, 153 incident diabetics. Results: We found that a high haem iron intake increases the risk of T2DM by 30%. In addition, SF values >257µg/L in males and >139µg/L in females were associated with T2DM. We also found association between sTfR:ferritin ratio and T2DM, but not with sTfR. Both SF and sTfR were related to osteocalcin. Conclusions: In an adult Mediterranean population at high cardiovascular risk, high dietary haem iron and body iron stores increase the risk of T2DM after adjustment for potential confounding variables. The relationship between iron status and serum osteocalcin levels is controversial.
Dubreil, Chloé. "Nanoparticules tolérogènes pour l’administration d’un auto-antigène des cellules bêta dans le diabète auto-immun Tolerogenic iron oxide nanoparticles in type 1 diabetes: biodistribution and pharmacokinetics studies in nonobese diabetic mice Tolerogenic nanoparticles boost regulatory B cells to reverse autoimmune diabetes." Thesis, Sorbonne Paris Cité, 2018. http://www.theses.fr/2018USPCB141.
Повний текст джерелаChronic autoimmune diseases are the consequence of self-antigens recognition as foreign by the adaptive immune system, resulting in inflammation and potential destruction of targeted tissues and organs. Type 1 diabetes (T1D) is one of the most common chronic autoimmune diseases. It is characterized by insulin deficiency due to selective destruction of insulin-producing beta-cells. At clinical onset, more than 70% of beta-cell mass can be destroyed. Consequently, early diagnosis is a major objective in order to avoid, limit or reverse autoimmune aggression, and to create opportunities for strategies enhancing beta-cell survival or regeneration. Antigen (Ag)-specific approaches are appealing because their effects are expected to be limited to cells expressing the chosen antigen, ideally the target organ. However, while treatment with beta -cell Ags can prevent disease in the model of the Non-Obese Diabetic (NOD) mouse, clinical trials in humans have produced disappointing results. Consequently, combinatorial approaches may be required for reversal and prevention of T1D. A potential strategy is to associate self-antigens with signals inducing a tolerogenic phenotype. Co-delivery ensures that both compounds get delivered at the same time and presented in the same cellular environment to auto-reactive immune cells. The first part of this work consisted in undertaking a thorough physicochemical characterization of a new drug vector, aiming to establish quantitative methods to optimize drug loading while maintaining biocompatibility and stability of the delivery vehicle. In this work, 9nm Ultra-small superparamagnetic iron-oxide (USPIO) nanoparticles were surface functionalized with phosphonate polyethylene glycol molecules (USPIO-PEG). Carboxylic acid functions were used to covalently bind a T1D autoantigen. PEG brush allows for the co-packaging of hydrophobic tolerogenic drug molecules, trapped between PEG chains through hydrophobic interactions. We carefully characterized protein and tolerogenic drug loading, and studied cell labeling, toxicity, integrity of loaded protein and tolerogenic drug, and activity of our nanoplatform on murine Bone Marrow Derived Dendritic Cells (BMDCs). We undertook biodistribution and pharmacokinetics studies using the NOD model that shares numerous features with human T1D. Biokinetic studies were performed both qualitatively using MRI 7T and histological Perls staining analyses and quantitatively using magnetometry for NP quantification. USPIO accumulate preferentially in NOD mice pancreas via Enhanced Permeability retention (EPR) effect thus, allowing us to distinguish pre-diabetic mice from non-diabetic controls. This result suggests that vascular leakage could be exploited for NP bioaccumulation, for therapeutic agent delivery and for imaging using MRI agents to monitor treatment. The second part of the work consisted in evaluating the therapeutic effect of such tolerogenic nanoparticles (NPS) on NOD diabetic mice. Diabetic mice were injected intravenously at diabetes onset. USPIO-PEG and vehicle treated mice reached 600mg/dL blood glucose level, considered limit for sacrificing mice, within a couple of days. NPs carrying either the tolerogenic drug or the autoantigen delayed diabetes progression up to 40 days. Complete NPs showed synergistic effects. In fact, 50% of treated mice were still alive 65 days after disease onset, and two mice reverted to stable normoglycemia for more than 300 days. To identify the underlying mechanism, the immune response to NPs in lymphoid organs was investigated. It was found that tolerogenic NPs induce splenomegaly mainly due to B cell proliferation. NP-stimulated B cells secrete anti-inflammatory cytokines namely IL-10 and TGF-beta. Similar B cells could be produced in vitro upon incubation of with NPs. Our strategy has promising therapeutic potential and could be applied, using relevant antigens, to a wider range of autoimmune diseases
Olivatto, Gabriela Marsola. "Caracterização sociodemográfica e clínica de pacientes com talassemia maior e diabetes mellitus de um centro de referência no interior de São Paulo." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/22/22132/tde-28112017-150253/.
Повний текст джерелаThe longer life expectancy of patients with thalassemia major, repeated red blood cell transfusions as part of the treatment, may lead to increased iron deposition in the organs, and consequently, comorbidities. Thus, among the endocrine comorbidities, we have diabetes mellitus as one of the main ones, being necessary to know the panorama in our reality. The aim of the study was to determine the prevalence of diabetes in patients with thalassemia major and to characterize and compare patients with thalassemia major, and diabetes mellitus, according to sociodemographic and clinical variables.This is a descriptive and cross-sectional study, carried out in a reference center in thalassemia treatment of São Paulo countryside. The sample consisted of 31 patients with thalassemia major. For data collection, an instrument was divided into two parts. Sociodemographic and clinical data were obtained by means of a directed interview and the laboratory tests results by the patient\'s electronic record, from June to August 2015. Data were loaded into SPSS for Windows software, version 17.0 and submitted to descriptive statistical analysis. The project was approved by the Research Ethics Committee of the University of São Paulo at Ribeirão Preto College of Nursing (CEP / EERP-USP) under Protocol No. 41912415.3.0000.5393. Of the 31 patients with thalassemia major, 5 (16,1%) had diabetes mellitus. Regarding the sociodemographic variables, there were no differences in the distribution of the patients between the sexes, most of them were single and enrolled in high school. The age ranged from five to 48 years, with a mean of 24,9 years of age, the majority received up to 10 minimum wages, were students and had a work contract. Regarding the clinical variables, we have that the predominant treatment was the oral chelator deferasirox, and in those patients with diabetes, in addition to deferasirox, the majority used insulin. The predominant transfusion regimen was 15 to 22 days. Body mass index was classified as eutrophic and blood pressure was considered optimal for most patients. Regarding the laboratory findings, patients with diabetes and thalassemia had altered values of fasting glycemia and transaminase, whereas patients without diabetes had altered values of serum ferritin. Regarding imaging exams findings, no patient with diabetes and major thalassemia presented adequate bone mass, which reinforces the importance of their monitoring. The increase in cardiac overload for patients with diabetes and thalassemia stands out. For patients with thalassemia and without diabetes, the majority had severe hepatic iron overload in the magnetic resonance imaging of the liver, while for most patients with diabetes it was considered normal. Thus, knowing the clinical characteristics of patients with thalassemia major and diabetes allows subsidizing qualified nursing care and contributing to the health of patients with chronic conditions. However, our findings corroborate the prevalence rates of diabetes in patients with thalassemia major found in the national and international literature
Steed, Kevin Sage. "Alzheimer's Disease and Diabetes: A Transgenic Mouse Model in Behavior, MRI, and Cells." BYU ScholarsArchive, 2018. https://scholarsarchive.byu.edu/etd/7460.
Повний текст джерелаSuarez, Ortegon Milton Fabian. "Markers of iron status and cardiometabolic disease risk : an exploration of the association based on cross-sectional and prospective studies in multiple populations." Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/31470.
Повний текст джерелаVirasith, Helene. "Long-chain polyunsaturated fatty acids and iron status in infants of gestational diabetic mothers." Thesis, McGill University, 2010. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=86758.
Повний текст джерелаL'acide arachidonique (AA), l'acide docosahexaénoïque (DHA) et le fer sont d'importants nutriments pour le nouveau-né. Il semblerait que leurs niveaux sont compromis chez les enfants de mères diabétiques (EMD). L'objectif de cette étude est de comparer les niveaux d'AA, de DHA et de fer chez les EMD avec ceux mesurés chez les enfants de mères non diabétiques qui sont nés avec un poids moyen ou gros pour l'âge gestationnelle pour déterminer si les niveaux de gras insaturés à longues chaînes et de fer sont tous les deux amoindris chez l'enfant. L'analyse de covariance entre le fer et les gras insaturés a montré que le niveau de fer est positivement corrélé avec le niveau d'AA mais pas avec celui de DHA. Chez les EDM, le lien entre le fer et l'AA est encore plus marquant. Ces résultats suggèrent que le niveau de fer est relié avec le niveau d'AA chez tous les nouveau-nés et qu'il y a un plus grand risque chez les EDM d'avoir un niveau d'AA amoindri et par conséquent de souffrir de problèmes de croissance.
Kuek, Conchita Maria. "Hereditary haemochromatosis and the C282Y genotype : implications in diagnosis and disease." University of Western Australia. School of Surgery and Pathology, 2003. http://theses.library.uwa.edu.au/adt-WU2004.0024.
Повний текст джерелаGONÇALVES, RODOLFO D. M. R. "Avaliação de micronutrientes e sua influência no metabolismo secundário de Bidens pilosa e Salvia officinalis, plantas usadas no tratamento de diabetes." reponame:Repositório Institucional do IPEN, 2015. http://repositorio.ipen.br:8080/xmlui/handle/123456789/26385.
Повний текст джерелаMade available in DSpace on 2016-06-22T13:06:23Z (GMT). No. of bitstreams: 0
Dissertação (Mestrado em Tecnologia Nuclear)
IPEN/D
Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP
Книги з теми "Diabetes Iran"
Rogers, Thomas R., and Elizabeth M. Johnson. Mucoraceous moulds. Edited by Christopher C. Kibbler, Richard Barton, Neil A. R. Gow, Susan Howell, Donna M. MacCallum, and Rohini J. Manuel. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755388.003.0018.
Повний текст джерелаЧастини книг з теми "Diabetes Iran"
Moghaddam-Banaem, Lida. "Maternal Diabetes in Pregnancy: Iran Perspectives." In Nutrition and Diet in Maternal Diabetes, 71–76. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56440-1_7.
Повний текст джерелаSarraf-Zadegan, Nizal, and Firoozeh Sajady. "Hypertension and Diabetes Situation in the Eastern Mediterranean Region: With Special Reference to Iran." In Progress in Experimental Cardiology, 451–72. Boston, MA: Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0455-9_33.
Повний текст джерелаMahdavi, Atena, Sajjad Moradi, Gholamreza Askari, Bijan Iraj, Thozhukat Sathyapalan, Paul C. Guest, Mohammad Bagherniya, and Amirhossein Sahebkar. "Effect of Curcumin on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review of Randomized Clinical Trials." In Studies on Biomarkers and New Targets in Aging Research in Iran, 139–49. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-56153-6_8.
Повний текст джерелаJohn, W. Garry, and Tara Wallace. "Diabetes and Iron-Deficiency Anaemia." In HbA1cin Diabetes, 65. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444320343.ch37.
Повний текст джерелаHininger-Favier, Isabelle, Jean-Marc Moulis, and Jean-Marc Ayoubi. "Iron and Oxidative Stress in Gestational Diabetes." In Nutrition and Diet in Maternal Diabetes, 479–91. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56440-1_36.
Повний текст джерелаCai, Lu. "Role of Iron in the Pathogenesis of Diabetes and Metabolic Syndrome." In Metabolic Syndrome and Neurological Disorders, 335–61. Chichester, UK: John Wiley & Sons Ltd, 2013. http://dx.doi.org/10.1002/9781118395318.ch21.
Повний текст джерелаKhuttar, Alaa Musa, Karim Al-Jeboury, and Kevin Mcdonald. "Mobile Phone Technologies and Diabetes: a Project for Self-Management and Education." In Reimagining Research for Reclaiming the Academy in Iraq: Identities and Participation in Post-Conflict Enquiry, 79–87. Rotterdam: SensePublishers, 2012. http://dx.doi.org/10.1007/978-94-6091-897-1_7.
Повний текст джерелаMandal, Sacira. "Association Between Serum Concentrations of Free Fatty Acids with Free Iron in Type 2 Diabetes." In IFMBE Proceedings, 423–32. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-73909-6_48.
Повний текст джерелаGurney, Travis O., Patrick J. Oliver, Sean M. Sliman, Anita Yenigalla, Timothy D. Eubank, Drew M. Nassal, Jiaxing Miao, Jing Zhao, Thomas J. Hund, and Narasimham L. Parinandi. "Hyperglycemic Oxoaldehyde (Glyoxal)-Induced Vascular Endothelial Cell Damage Through Oxidative Stress Is Protected by Thiol Iron Chelator, Dimercaptosuccinic Acid – Role of Iron in Diabetic Vascular Endothelial Dysfunction." In Cardiovascular Signaling in Health and Disease, 485–523. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-08309-9_18.
Повний текст джерелаAllen, K. J. "Haemochromatosis." In Oxford Textbook of Endocrinology and Diabetes, 1684–94. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199235292.003.1258.
Повний текст джерелаТези доповідей конференцій з теми "Diabetes Iran"
"Common Signs and Symptoms in Patients with Type II Diabetes in Iran." In International Institute of Chemical, Biological & Environmental Engineering. International Institute of Chemical, Biological & Environmental Engineering, 2015. http://dx.doi.org/10.15242/iicbe.c0615090.
Повний текст джерелаMozaffari, Abolfazl, and Maryam Hendiani. "Study on prevalence and associated factors of Diabetes Mellitus among Tuberculosis Patients in Iran." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2971.
Повний текст джерела"Diet History in Patients with Type1 and Type 2 Diabetes in Eslamshahr-Tehran, Iran." In International Conference on Food, Biological and Medical Sciences. International Institute of Chemical, Biological & Environmental Engineering, 2014. http://dx.doi.org/10.15242/iicbe.c0114602.
Повний текст джерелаAghniya, Rofana, Bhisma Murti, Didik Gunawan Tamtomo, and Hanung Prasetya. "The Effect of Depression Comorbidity on the Quality of Life of Patients with Type 2 Diabetes Mellitus: Meta-Analysis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.01.56.
Повний текст джерела"Familial History and Psychological Problems: High Risk Factors for Type 2 Diabetes in Hamedan (Northwestern Iran)." In International Conference on Chemical, Agricultural and Medical Sciences. International Institute of Chemical, Biological & Environmental Engineering, 2014. http://dx.doi.org/10.15242/iicbe.c514079.
Повний текст джерела"Glutathione S-transferase M1 genotype polymorphisms and type 2 diabetes risk in Zoroastrian female in Yazd, Iran." In International Conference on Medicine, Public Health and Biological Sciences. CASRP Publishing Company, Ltd. Uk, 2016. http://dx.doi.org/10.18869/mphbs.2016.104.
Повний текст джерелаBabarykin, Dmitry, Gaļina Smirnova, Svetlana Vasiļjeva, Anna Fedotova, Andrey Fedotov, and Natālija Basova. "Evaluation of the biological activity of sugar-free fractionated red beetroot juice." In 80th International Scientific Conference of the University of Latvia. University of Latvia, 2023. http://dx.doi.org/10.22364/iarb.2022.05.
Повний текст джерелаAli, Rusul Arif Abd, Zahraa Kareem Al-Mayali, and Wijdan Rajh Hamza Al-Kraity. "Relation between iron status and hemoglobin in hepatitis patient with diabetes undergo hemodialysis." In 3RD INTERNATIONAL SCIENTIFIC CONFERENCE OF ALKAFEEL UNIVERSITY (ISCKU 2021). AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0067430.
Повний текст джерелаMahmood, Shukur, Majid Maatook, and Dhaigham Aatwan. "Risk Factors of Glycaemia Control among Children and Adolescents with Type 1 Diabetes in Basra City/Iraq." In Proceedings of 2nd International Multi-Disciplinary Conference Theme: Integrated Sciences and Technologies, IMDC-IST 2021, 7-9 September 2021, Sakarya, Turkey. EAI, 2022. http://dx.doi.org/10.4108/eai.7-9-2021.2314899.
Повний текст джерелаIstepanian, Robert S. H., Alaa Mousa, Nazar Haddad, Ala Sungoor, Thamer Hammadan, Handrean Soran, and Turki Al-Anzi. "The potential of m-health systems for diabetes management in post conflict regions a case study from Iraq." In 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2014. http://dx.doi.org/10.1109/embc.2014.6944414.
Повний текст джерела